Danish Angle Closure Prevention Trial
Key facts
- Where
- Aalborg, Aarhus, Glostrup Municipality, Odense, and Vejle, DenmarkSee the 5 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT06077253, who can take part
Where in Denmark
- Aalborg University HospitalAalborg, DenmarkTaking people
- Aarhus University HospitalAarhus, DenmarkTaking people
- Rigshospitalet GlostrupGlostrup Municipality, DenmarkTaking people
- Odense University HospitalOdense, DenmarkNot yet recruiting
- Sygehus LillebæltVejle, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Aarhus
- Trial code
- NCT06077253
- Record updated
- 13 November 2023
- Original description
To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.Read full original descriptionShow less
To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.
Inclusion: Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy; Best-corrected visual acuity (BCVA) >0.8 on both eyes; Caucasian.
Exclusion: Previous iridotomy; Clinically significant cataract with indication for surgery,; Systemic or ocular corticosteroid treatment; Unstable retinal conditions; Ocular malignancies; Pseudophakia; Gaucoma; Uveitis; PEX; PDS.